JP2021527671A5 - - Google Patents
Info
- Publication number
- JP2021527671A5 JP2021527671A5 JP2020570747A JP2020570747A JP2021527671A5 JP 2021527671 A5 JP2021527671 A5 JP 2021527671A5 JP 2020570747 A JP2020570747 A JP 2020570747A JP 2020570747 A JP2020570747 A JP 2020570747A JP 2021527671 A5 JP2021527671 A5 JP 2021527671A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- amino acid
- composition
- dipeptide
- tripeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687727P | 2018-06-20 | 2018-06-20 | |
| US62/687,727 | 2018-06-20 | ||
| US201962794134P | 2019-01-18 | 2019-01-18 | |
| US62/794,134 | 2019-01-18 | ||
| PCT/US2019/038037 WO2019246299A1 (en) | 2018-06-20 | 2019-06-19 | Compositions and methods for the reduction or treatment of insulin resistance and metabolic conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527671A JP2021527671A (ja) | 2021-10-14 |
| JP2021527671A5 true JP2021527671A5 (cg-RX-API-DMAC7.html) | 2022-09-08 |
Family
ID=67185732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570747A Pending JP2021527671A (ja) | 2018-06-20 | 2019-06-19 | インスリン抵抗性及び代謝疾患の軽減又は治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20210275479A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3810122A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021527671A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112689508A (cg-RX-API-DMAC7.html) |
| MA (1) | MA52953A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019246299A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| BR112020025831A2 (pt) | 2018-06-20 | 2021-03-23 | Axcella Health Inc. | métodos de fabricação de composições de aminoácidos |
| CN111514276B (zh) * | 2020-06-29 | 2021-07-27 | 黑龙江中医药大学 | 短肽Asp-His-Tyr在制备治疗多囊卵巢综合征的药物中的应用 |
| WO2022266480A1 (en) * | 2021-06-17 | 2022-12-22 | Axcella Health Inc. | Methods of predicting liver fat content and uses thereof |
| US11737999B2 (en) | 2021-07-26 | 2023-08-29 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19 |
| EP4643658A1 (en) * | 2024-04-29 | 2025-11-05 | Laboratorios Ern S.A. | Dietary product for hypoproteic diet |
| CN119679774B (zh) * | 2024-11-15 | 2026-05-08 | 北京体育大学 | 预防或治疗代谢性疾病的药物及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02007466A (es) * | 2000-02-01 | 2004-02-26 | Muscletech Res And Dev Inc | Suplemento alimenticio a base de acido alfa-lipoico para incrementar la masa muscular escas y la fuerza. |
| US20050176827A1 (en) * | 2002-05-10 | 2005-08-11 | Lee Steve S. | Compositions and methods for glycogen synthesis |
| CN1557301A (zh) * | 2004-01-15 | 2004-12-29 | 高春平 | 降低老年肥胖型糖尿病人血糖和血脂的组合物 |
| US20050233014A1 (en) * | 2004-03-02 | 2005-10-20 | Lee Steve S | Methods for affecting homeostasis and metabolism in a mammalian body |
-
2019
- 2019-06-19 MA MA052953A patent/MA52953A/fr unknown
- 2019-06-19 JP JP2020570747A patent/JP2021527671A/ja active Pending
- 2019-06-19 WO PCT/US2019/038037 patent/WO2019246299A1/en not_active Ceased
- 2019-06-19 CN CN201980054586.0A patent/CN112689508A/zh active Pending
- 2019-06-19 EP EP19736883.0A patent/EP3810122A1/en not_active Withdrawn
- 2019-06-19 US US17/254,027 patent/US20210275479A1/en not_active Abandoned
-
2023
- 2023-07-27 US US18/360,381 patent/US20240238232A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020530845A5 (cg-RX-API-DMAC7.html) | ||
| JP2020504108A5 (cg-RX-API-DMAC7.html) | ||
| JP2021529736A5 (cg-RX-API-DMAC7.html) | ||
| JP2020502183A5 (cg-RX-API-DMAC7.html) | ||
| He et al. | Amino acid nutrition and metabolism in chickens | |
| Garibotto et al. | Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease | |
| Bertrand et al. | Regulation of intestinal protein metabolism by amino acids | |
| TWI777999B (zh) | 胺基酸組合物及肝疾病之治療方法 | |
| TW201919601A (zh) | 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法 | |
| GB1511302A (en) | Pharmaceutical compositions comprising amino acid analogues | |
| US20060247313A1 (en) | Amino acid composition promoting collagen synthesis | |
| CN1301155A (zh) | γ-氨基丁酸衍生物的稳定药物制剂和其制备方法 | |
| JP2016527277A5 (cg-RX-API-DMAC7.html) | ||
| RU2008126294A (ru) | Способы лечения потери мышечной массы | |
| JP2009538832A5 (cg-RX-API-DMAC7.html) | ||
| JPS61247354A (ja) | 栄養素組成物 | |
| FI3746467T3 (fi) | Muutetut lipidoidut relaksiinin b-ketjun peptidit ja niiden terapeuttinen käyttö | |
| WO2007043870A1 (en) | Leucine rich composition | |
| CN112689508A (zh) | 减少或治疗胰岛素抗性和代谢病状的组合物和方法 | |
| JP2004521123A5 (cg-RX-API-DMAC7.html) | ||
| JP2011523626A5 (cg-RX-API-DMAC7.html) | ||
| JP2010513259A5 (cg-RX-API-DMAC7.html) | ||
| EP1849466A3 (en) | Infusion fluid for dialysis patients | |
| van der Hulst et al. | The effect of glutamine administration on intestinal glutamine content | |
| JP2023516957A5 (cg-RX-API-DMAC7.html) |